>> ALL RIGHT. WHAT HAPPENED TO THE STOCK IN NOVO NORDISK. THE DANISH DRUG COMPANY, YOU KNOW, IS THE INVENTOR OF OZEMPIC AND WEGOVY.LAST WEEK, THEY REPORTED A BEAT AND RAISE QUARTER. YET THE STOCK FELL NEARLY 6% THE DAY THOSE NUMBERS WERE RELEASED. SINCE THEN, WELL, IT MADE UP MOST OF ITS LOSSES, BUT THAT WAS A STUNNING REACTION.HEY, KEEP IN MIND, NOVO NORDISK HELPED INVENT THE GLP ONE CATEGORY, AND THEIR OBESITY AND DIABETES BUSINESSES ARE NOW PRINTING MONEY. IN JANUARY, THEY LAUNCHED A PILL VERSION OF WEGO ...

After curbing allocations earlier this year, the $109 billion fund behind Novo Nordisk is investing again and eyeing attractively priced opportunities in the US https://t.co/sMitREyHht ...